elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33709790-60D216A8-4B1A-4001-866F-EE88B6058485
Q33709790-60D216A8-4B1A-4001-866F-EE88B6058485
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33709790-60D216A8-4B1A-4001-866F-EE88B6058485
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
P2860
Q33709790-60D216A8-4B1A-4001-866F-EE88B6058485
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33709790-60D216A8-4B1A-4001-866F-EE88B6058485
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41006b6a9e5551e8bbc11b72e27cb9a5f05392e1
P2860
SLFN11 inhibits checkpoint maintenance and homologous recombination repair.